Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05514912
Title Preoperative Nab-paclitaxel, Cisplatin, and Gemcitabine Chemotherapy With or Without Infigratinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, The OPTIC Trial
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Emory University
Indications

intrahepatic cholangiocarcinoma

Therapies

Cisplatin + Gemcitabine + Nab-paclitaxel

Cisplatin + Gemcitabine + Infigratinib + Nab-paclitaxel

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST